What's Happening?
Atossa Therapeutics and Calidi Biotherapeutics are set to appear on the RedChip Small Stocks, Big Money show on Bloomberg TV. Calidi Biotherapeutics will discuss its RedTail platform, a viral therapy designed to deliver genetic medicines to treat tumors, showcasing promising preclinical data. Atossa Therapeutics will highlight its lead clinical candidate, (Z)-endoxifen, aimed at redefining breast cancer treatment. Both companies are advancing their respective technologies with the potential to significantly impact the oncology market.
AD
Why It's Important?
The interviews on Bloomberg TV provide Atossa Therapeutics and Calidi Biotherapeutics with a platform to reach a wide audience, potentially attracting investors and partners. Calidi's RedTail platform and Atossa's (Z)-endoxifen represent innovative approaches in cancer treatment, addressing unmet needs in oncology. Their advancements could lead to improved patient outcomes and offer substantial shareholder value. The exposure on Bloomberg TV could accelerate their development and commercialization efforts.
